CervoMed Inc. (CRVO)
CRVO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.27
-9.56% on the day
Market cap
$34.3M
Nano cap
Revenue · 2025
$4.0M
-58.9% on 2024
Net income · 2025
-$27.0M
-673.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CRVO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001053691 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.0M |
| Net income | -$27.0M |
| Operating income | -$28.3M |
| Net margin | -673.2% |
| Operating margin | -706.2% |
| Revenue growth | -58.9% |
| Cash | $8.2M |
| Total assets | $22.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 8.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2026-07-10 |
| Latest annual report FORM 10-K | 10-K | 2026-03-13 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-07 |
| Latest current report FORM 8-K | 8-K | 2026-10-14 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 999 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
| FLNA | Filana Therapeutics Inc. | $0.7434 | -3.39% | $35.9M |
| JAGX | Jaguar Health Inc. | $4.16 | -10.35% | $32.5M |
| GRDX | GridAI Technologies Corp. | $4.55 | -2.36% | $32.4M |
| CPHI | China Pharma Holdings Inc. | $0.7514 | -13.53% | $32.3M |
| BCTX | BriaCell Therapeutics Corp. Common Shares | $3.71 | -4.13% | $32.3M |
| IXHL | Incannex Healthcare Inc. | $2.91 | +0.34% | $36.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier